Apomorphine SC treatment in parkinsonian patients with long-term L-dopa syndrome during L-dopa drug holiday. 1995

L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
Department of Neurology, University of Turin, Italy.

The Long-Term Dopa Syndrome (LTDS) is one of the main problems in the management of advanced parkinsonian patients. A transient L-Dopa withdrawal (Drug Holiday, DH) can be useful to improve the drug response after DH, even if this approach presents risks due to patient akinesia. We tried to verify if Apomorphine sc administration during DH (DH with Apomorphine, DHA) can: a) reduce the risks connected with DH: b) maintain the benefits of DH: c) standardize the duration of DH. Twenty-five parkinsonian patients with LTDS were treated with Apomorphine sc during DH (14 days). No patient had any severe side effects. The follow-up at 180 days, conducted using the Unified Parkinson's Disease Rating Scale, demonstrated a significant improvement in the clinical conditions of about 70% of the patients, allowing a 27.1% reduction in daily L-dopa dosage. DHA can represent a valid therapeutical approach for parkinsonian patients with LTDS.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
March 1985, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
January 1981, Neurologia i neurochirurgia polska,
L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
July 1980, Neurology,
L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
January 1972, International journal of neurology,
L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
October 1974, Rivista di patologia nervosa e mentale,
L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
January 1970, Sistema nervoso,
L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
January 1973, Neurologia, psihiatria, neurochirurgia,
L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
January 1973, Neurologia, psihiatria, neurochirurgia,
L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
January 1993, Neurourology and urodynamics,
L Scarzella, and M Delsedime, and B Ferrero, and C Giangrandi, and L Priano, and M Rizzone, and B Bergamasco
January 1975, Acta neurologica latinoamericana,
Copied contents to your clipboard!